(0.72%) 5 118.75 points
(0.09%) 38 324 points
(0.99%) 17 742 points
(0.60%) $84.07
(-3.79%) $1.576
(0.72%) $2 359.40
(0.96%) $27.62
(0.47%) $924.80
(0.01%) $0.932
(0.39%) $10.99
(-0.06%) $0.799
(-0.30%) $91.89
@ NOK7.10
Issued: 26 Apr 2024 @ 03:53
Return: 1.27%
Previous signal: Apr 25 - 09:41
Previous signal:
Return: 1.14 %
Live Chart Being Loaded With Signals
Ultimovacs ASA, a pharmaceutical company, develops immunotherapies for cancers. Its lead product candidate is UV1, a peptide-based vaccine that induces T cell response against the universal cancer antigen telomerase...
Stats | |
---|---|
Today's Volume | 190 016 |
Average Volume | 1.53M |
Market Cap | 247.31M |
EPS | NOK0 ( 2024-02-14 ) |
Next earnings date | ( NOK0 ) 2024-05-06 |
Last Dividend | NOK0 ( N/A ) |
Next Dividend | NOK0 ( N/A ) |
P/E | -1.310 |
ATR14 | NOK0.407 (5.67%) |
Volume Correlation
Ultimovacs ASA Correlation
10 Most Positive Correlations | |
---|---|
AUSS.OL | 0.945 |
IDEX.OL | 0.94 |
LSG.OL | 0.931 |
NBX.OL | 0.93 |
EFUEL.OL | 0.911 |
TEL.OL | 0.907 |
ADE.OL | 0.902 |
AFG.OL | 0.887 |
ELIMP.OL | 0.885 |
SSG.OL | 0.872 |
10 Most Negative Correlations | |
---|---|
FROY.OL | -0.962 |
TRE.OL | -0.9 |
NORSE.OL | -0.899 |
SPOG.OL | -0.843 |
ECIT.OL | -0.839 |
NODL.OL | -0.837 |
BWLPG.OL | -0.825 |
KAHOT.OL | -0.819 |
IWS.OL | -0.816 |
TRVX.OL | -0.815 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Ultimovacs ASA Correlation - Currency/Commodity
Ultimovacs ASA Financials
Annual | 2023 |
Revenue: | NOK0 |
Gross Profit: | NOK-2.77M (0.00 %) |
EPS: | NOK-5.50 |
FY | 2023 |
Revenue: | NOK0 |
Gross Profit: | NOK-2.77M (0.00 %) |
EPS: | NOK-5.50 |
FY | 2022 |
Revenue: | NOK0 |
Gross Profit: | NOK-2.65M (0.00 %) |
EPS: | NOK-4.29 |
Financial Reports:
No articles found.
Ultimovacs ASA
Ultimovacs ASA, a pharmaceutical company, develops immunotherapies for cancers. Its lead product candidate is UV1, a peptide-based vaccine that induces T cell response against the universal cancer antigen telomerase. The company was incorporated in 2011 and is headquartered in Oslo, Norway.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators